Core Viewpoint - Danone is proactively recalling specific batches of infant formula products in response to evolving food safety guidance from local authorities, emphasizing its commitment to food safety and consumer trust [1][2]. Group 1: Recall Announcement - Danone will withdraw a limited number of specific batches of infant formula products from targeted markets to comply with the latest food safety guidance [2]. - The company reassures that its products are safe and fully compliant with all applicable safety regulations [1][2]. Group 2: Company Overview - Danone is a leading global food and beverage company focused on health-oriented categories, including Essential Dairy & Plant-Based products, Waters, and Specialized Nutrition [4]. - The company generated €27.4 billion in sales in 2024 and operates in over 120 markets with a workforce of more than 90,000 employees [4]. - Danone's portfolio includes well-known international brands such as Actimel, Activia, and evian, as well as strong local brands [4].

Core Viewpoint - A class action lawsuit has been filed against Perrigo Company plc for failing to disclose significant issues in its infant formula business, leading to overstated financial results and subsequent stock price decline [2][8]. Allegation Details - The lawsuit alleges that Perrigo did not disclose: 1. Significant underinvestment in maintenance and operational improvements in the infant formula business acquired from Nestlé [8]. 2. The need for substantial capital and operational expenditures beyond previously stated estimates to remediate the infant formula business [8]. 3. Significant manufacturing deficiencies in the infant formula facility [8]. 4. The impact of these issues resulted in overstated financial results, including earnings and cash flow [8]. Financial Impact - On November 5, 2025, Perrigo announced disappointing financial results for Q3 2025, leading to a reduction in its fiscal year 2025 outlook primarily due to challenges in the infant formula industry [8]. - Following this announcement, Perrigo's stock price fell by $5.09, or 25.2%, closing at $15.10 per share on the same day [8].

Core Viewpoint - A class action lawsuit has been filed against Perrigo Company plc for failing to disclose significant issues in its infant formula business, leading to investor losses during the class period from February 27, 2023, to November 4, 2025 [2][7]. Allegation Details - The lawsuit alleges that Perrigo did not disclose the following: 1. The infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance and operational improvements [7]. 2. Perrigo needed to make substantial capital and operational expenditures beyond previously stated cost estimates to remediate the infant formula business [7]. 3. There were significant manufacturing deficiencies in the facility for the infant formula business [7]. 4. As a result, the Company's financial results, including earnings and cash flow, were overstated [7]. Financial Impact - On November 5, 2025, Perrigo announced disappointing financial results for Q3 2025, leading to a significant reduction in its fiscal year 2025 outlook due to issues in the infant formula industry [7]. - The announcement included a reassessment of a previously announced investment of $240 million in the infant formula business, which was deemed "less strategic" [7]. - Following this news, Perrigo's stock price fell by $5.09, or 25.2%, closing at $15.10 per share on the same day [7].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Perrigo Company plc regarding a class action lawsuit due to alleged misleading statements and operational deficiencies related to the company's infant formula business acquired from Nestlé [1][2]. Group 1: Allegations - The complaint alleges that during the class period from February 27, 2023, to November 4, 2025, Perrigo issued materially false and misleading statements [1]. - Specific allegations include significant underinvestment in maintenance and operational improvements for the infant formula business, necessitating substantial capital and operational expenditures beyond stated cost estimates [1]. - The complaint also highlights significant manufacturing deficiencies in the facility for the infant formula business, leading to overstated financial results, including earnings and cash flow [1]. Group 2: Class Action Details - Shareholders who purchased PRGO shares during the specified class period are encouraged to register for the class action, with a deadline of January 16, 2026, to seek lead plaintiff status [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Perrigo Company plc securities between February 27, 2023, and November 4, 2025, of the January 16, 2026, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Perrigo securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by January 16, 2026, to serve as lead plaintiff [2] - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, which suffered from underinvestment and significant manufacturing deficiencies [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [3] - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [3]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Perrigo Company plc securities between February 27, 2023, and November 4, 2025, of the January 16, 2026, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Perrigo securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by January 16, 2026, to serve as lead plaintiff [2] - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3] Group 2: Allegations Against Perrigo - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business acquired from Nestlé, which suffered from significant underinvestment in maintenance [4] - It is claimed that Perrigo needed to make substantial capital and operational expenditures beyond its stated cost estimates to remediate the infant formula business [4] - The lawsuit also states that there were significant manufacturing deficiencies in the facility for Perrigo's infant formula business, leading to overstated financial results, including earnings and cash flow [4]

Core Viewpoint - A class action lawsuit has been filed against Perrigo Company plc for failing to disclose significant issues related to its infant formula business, leading to investor losses during the specified class period [2][8]. Allegation Details - The lawsuit alleges that Perrigo did not disclose the following critical issues: 1. The infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance and operational improvements [8]. 2. Perrigo needed to make substantial capital and operational expenditures beyond previously stated cost estimates to remediate the infant formula business [8]. 3. There were significant manufacturing deficiencies in the facility for the infant formula business [8]. 4. As a result of these issues, the Company's financial results, including earnings and cash flow, were overstated [8]. Financial Impact - On November 5, 2025, Perrigo announced disappointing financial results for Q3 2025, leading to a significant reduction in its fiscal year 2025 outlook due to "infant formula industry dynamics" [8]. - The same day, Perrigo initiated a strategic review of its infant formula business, reassessing a previously announced investment of $240 million, indicating the business had become "less strategic" [8]. - Following this announcement, Perrigo's stock price fell by $5.09, or 25.2%, closing at $15.10 per share on November 5, 2025 [8].

Core Viewpoint - A class action securities lawsuit has been filed against Perrigo Company plc, alleging securities fraud that affected investors between February 27, 2023, and November 4, 2025 [1] Group 1: Allegations of Fraud - The lawsuit claims that Perrigo's infant formula business, acquired from Nestlé, suffered from significant underinvestment in maintenance and operational improvements [2] - It is alleged that Perrigo needed to make substantial capital and operational expenditures beyond previously stated cost estimates to remediate issues in the infant formula business [2] - The complaint states that there were significant manufacturing deficiencies in the facility for the infant formula business [2] - As a result of these issues, Perrigo's financial results, including earnings and cash flow, were overstated [2] - The positive statements made by the defendants regarding the Company's business and prospects were materially misleading and lacked a reasonable basis [2] Group 2: Legal Process and Participation - Investors who suffered losses during the relevant time frame have until January 16, 2026, to request to be appointed as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the top securities litigation firms in the United States [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Perrigo Company plc securities between February 27, 2023, and November 4, 2025, of the January 16, 2026, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Perrigo securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by January 16, 2026, to serve as lead plaintiff [2] - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, which suffered from underinvestment and significant manufacturing deficiencies [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [3] - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [3]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Perrigo Company plc regarding a class action lawsuit alleging that the company made materially false and misleading statements about its infant formula business and its financial results during the specified class period [1]. Allegations - The complaint claims that the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance, operational improvements, and repairs [1]. - Perrigo is alleged to have needed to make substantial capital and operational expenditures beyond the company's stated cost estimates to remediate the infant formula business [1]. - There were significant manufacturing deficiencies identified in the facility for the infant formula business [1]. - As a result of these issues, the company's financial results, including earnings and cash flow, were overstated [1]. - The positive statements made by the defendants regarding the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [1]. Class Action Details - The class period for the lawsuit is from February 27, 2023, to November 4, 2025 [1]. - Shareholders are encouraged to register for the class action by January 16, 2026, to potentially be appointed as lead plaintiffs [2]. - There is no cost or obligation for shareholders to participate in the case [2]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who incurred losses due to misleading statements or omissions [3].